Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Recent studies add new data to breast cancer research
September 1st, 2005
Investigators in Spain, the United Kingdom and Italy have published new breast cancer data. Study 1: Overall survival is improved among women with node-positive breast cancer who receive adjuvant docetaxel compared with those receiving fluorouracil, study results indicate. "We compared docetaxel plus doxorubicin and cyclophosphamide (TAC) with fluorouracil plus doxorubicin and cyclophosphamide (FAC) as adjuvant chemotherapy for operable node-positive breast cancer. We randomly assigned 1,491 women with axillary node-positive breast cancer to 6 cycles of treatment with either TAC or FAC as adjuvant chemotherapy after surgery. The primary end point was...
Source: Women's Health Weekly (2005-09-01)
|
